AbbVie (NYSE: ABBV) today announced that it has completed its acquisition of Cerevel Therapeutics (NASDAQ: CERE). With the completion of the acquisition, Cerevel is now part of AbbVie.
Yahoo! Finance: CERE News
Enjoying Merger Arbitrage Limited?
Sign up then! It's quick and FREE
Have time to share an article? It's very much appreciated!!